Literature DB >> 26050949

FDG-PET/CT in Infectious and Inflammatory Diseases.

Søren Hess1, Susanne H Hansson2, Kasper T Pedersen3, Sandip Basu4, Poul Flemming Høilund-Carlsen3.   

Abstract

Nuclear medicine techniques have been an integral part of infection and inflammation imaging for decades; in recent years, fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) has taken over many indications. This review provides a comprehensive overview of the current and potential applications for FDG-PET/CT in infectious and inflammatory diseases (ie, systemic infections, bone infections, vascular infection and inflammation, thoracic and abdominal inflammation) and potential novel applications in both infection and inflammation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FDG; Fluorodeoxyglucose; Infection; Infectious disease; Inflammation; Inflammatory disease; PET/CT; Positron emission tomography/computed tomography

Mesh：

Substances：

Year:  2014        PMID： 26050949     DOI： 10.1016/j.cpet.2014.07.002

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  20 in total

1.  18F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study.

Authors:  Qian Wang; Ya-Ming Li; Yuan Li; Feng-Chun Hua; Quan-Shi Wang; Xiao-Li Zhang; Chao Cheng; Hua Wu; Zhi-Ming Yao; Wei-Fang Zhang; Qing-Yi Hou; Wei-Bing Miao; Xue-Mei Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-11       Impact factor: 9.236

2.  An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Authors:  Abass Alavi; Søren Hess; Thomas J Werner; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

Review 3.  Mapping COVID-19 functional sequelae: the perspective of nuclear medicine.

Authors:  Simone Cristina Soares Brandão; Júlia de Oliveira Xavier Ramos; Gustavo Freitas Alves de Arruda; Emmanuelle Tenório Albuquerque Madruga Godoi; Lara Cristiane Terra Ferreira Carreira; Rafael Willain Lopes; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

4.  Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma.

Authors:  Yimin Li; Frank Hofheinz; Christian Furth; Chen Lili; Wu Hua; Pirus Ghadjar; Sebastian Zschaeck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-21       Impact factor: 9.236

5.  Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy.

Authors:  Sebastian Zschaeck; Frank Hofheinz; Klaus Zöphel; Rebecca Bütof; Christina Jentsch; Julia Schmollack; Steffen Löck; Jörg Kotzerke; Gustavo Baretton; Jürgen Weitz; Michael Baumann; Mechthild Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-09       Impact factor: 9.236

Review 6.  Immune PET Imaging.

Authors:  Osigbemhe Iyalomhe; Michael D Farwell
Journal:  Radiol Clin North Am       Date:  2021-09       Impact factor: 1.947

7.  False-positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography in a patient with metallic implants following chondrosarcoma resection.

Authors:  P U Zhou; Jinliang Tang; Dong Zhang; Guanghui Li
Journal:  Mol Clin Oncol       Date:  2016-03-03

8.  Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.

Authors:  Amir Emamifar; Søren Hess; Oke Gerke; Anne Pernille Hermann; Helle Laustrup; Per Syrak Hansen; Peter Thye-Rønn; Niels Marcussen; Frank Svendstrup; Rannveig Gildberg-Mortensen; Jacob Christian Bang; Ziba Ahangarani Farahani; Stavros Chrysidis; Pia Toftegaard; Rikke Asmussen Andreasen; Sebastian le Greves; Hanne Randi Andersen; Rudolf Nezlo Olsen; Inger Marie Jensen Hansen
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

9.  Preclinical Multimodal Molecular Imaging Using 18F-FDG PET/CT and MRI in a Phase I Study of a Knee Osteoarthritis in In Vivo Canine Model.

Authors:  Maria I Menendez; Bianca Hettlich; Lai Wei; Michael V Knopp
Journal:  Mol Imaging       Date:  2017-01-01       Impact factor: 4.488

10.  In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer 68Ga-NODAGA-Procainamide (PCA).

Authors:  István Kertész; András Vida; Gábor Nagy; Miklós Emri; Antal Farkas; Adrienn Kis; János Angyal; Noémi Dénes; Judit P Szabó; Tünde Kovács; Péter Bai; György Trencsényi
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.